S&P 500 Futures
(0.12%) 5 333.75 points

Dow Jones Futures
(0.04%) 40 155 points

Nasdaq Futures
(0.20%) 18 673 points

Oil
(-0.42%) $79.72

Gas
(0.91%) $2.65

Gold
(1.19%) $2 446.20

Silver
(3.33%) $32.30

Platinum
(0.09%) $1 091.00

USD/EUR
(0.01%) $0.920

USD/NOK
(-0.09%) $10.67

USD/GBP
(0.02%) $0.787

USD/RUB
(-0.62%) $90.41

Realtime updates for ADMA Biologics Inc [ADMA]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

BUY

80.00%
return 4.89%

SELL

25.00%
return 1.40%

Last Updated17 May 2024 @ 16:00

25% discount on Stockinvest.us - Use code: Podcast

1.66% $ 9.21

SELL 137621 min ago

@ $5.32

Issued: 14 Feb 2024 @ 15:41

Return: 73.28%

Previous signal: Feb 14 - 13:10

Previous signal: Buy

Return: 0.90 %

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 16:00):

ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally...

Stats
Today's Volume	3.63M
Average Volume	2.87M
Market Cap	2.13B
EPS	$0 ( 2024-05-09 )
Next earnings date	( $0 ) 2024-08-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-460.50
ATR14	$0.0100 (0.11%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-01	Kestenberg-messina Kaitlin M.	Buy	192 320	Common Stock
2024-04-01	Kestenberg-messina Kaitlin M.	Buy	300 328	Stock Option (right to buy)
2024-03-31	Kestenberg-messina Kaitlin M.	Sell	2 085	Common Stock
2024-03-31	Grossman Adam S	Sell	21 752	Common Stock
2024-04-01	Kestenberg-messina Kaitlin M.	Sell	0	Common Stock

INSIDER POWER
-15.65
Last 100 transactions
Buy: 7 559 578 \| Sell: 9 852 560

Volume Correlation

Long: -0.34 (neutral)

Short: 0.69 (moderate)

Signal:(60.969) Neutral

ADMA Biologics Inc Correlation

10 Most Positive Correlations
IESC	0.938
USLM	0.928
SFM	0.927
APOG	0.924
WWD	0.92
XFIN	0.916
EM	0.915
AEYE	0.911
PI	0.904
GGAL	0.903

10 Most Negative Correlations
FRSH	-0.927
HSDT	-0.923
MRAM	-0.915
VRSN	-0.908
CVRX	-0.899
IART	-0.892
III	-0.892
OTEX	-0.892
BON	-0.891
FUV	-0.888

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

ADMA Biologics Inc Correlation - Currency/Commodity

0.08
( neutral )

0.20
( neutral )

0.00
( neutral )

-0.32
( neutral )

0.60
( weak )

-0.12
( neutral )

ADMA Biologics Inc Financials

Annual	2023
Revenue:	$258.21M
Gross Profit:	$88.22M (34.16 %)
EPS:	$-0.130

FY	2023
Revenue:	$258.21M
Gross Profit:	$88.22M (34.16 %)
EPS:	$-0.130

FY	2022
Revenue:	$154.08M
Gross Profit:	$35.27M (22.89 %)
EPS:	$-0.430

FY	2021
Revenue:	$80.94M
Gross Profit:	$1.17M (1.45 %)
EPS:	$-0.832

Financial Reports:

No articles found.

ADMA Biologics Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

ADMA Biologics Inc

ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. The company also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.